Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Krebs Biochemicals and Industries Ltd

KREBSBIO.NS ✗ NOT COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.57

▼ -2.38%

Market Cap $12.33M · Vol 3.92K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$12.33M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

47.01

Momentum

Beta

2.10

vs Market

52W High

$0.86

38.90% below

52W Low

$0.40

40.82% above

Volume

3.92K

Avg 9.69K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

18.88%

Public shares

Shariah Compliance8 STANDARDS

✗ Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does KREBSBIO.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.80%

-0.22%

-3.47%

-8.74%

YTD

-20.92%

-27.52%

-30.49%

-63.54%

Financials & Valuation

TTM · Annual

Total Revenue	$2.54M
Net Income	$-1,811,860.00
Revenue Growth (YoY)	+27.42%
Gross Margin	71.29%
Operating Margin	-50.03%
Net Profit Margin	-71.35%
ROE	N/A
ROA · ROIC	-10.19% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.61
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	21.56M

Technical Indicators

50-Day SMA	$0.61
200-Day SMA	$0.64
RSI (14)	47.01
Beta	2.10
52-Week High	$0.86
52-Week Low	$0.40

Volume Today	3.92K
Avg Daily Volume (30D)	9.69K
Relative Volume	0.40x
Volatility (10D)	38.31
Volatility (30D)	45.22
Free Float	18.88%

Analyst Consensus

N/A

Current Price $0.57

Mean Target N/A

52W Low$0.40 52W High$0.86

Current

Target

$0.40 $0.86

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S86T54

ISININE268B01013

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.